These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26914376)

  • 1. Cancer screening in Portugal: sex differences in prevalence, awareness of organized programmes and perception of benefits and adverse effects.
    Costa AR; Silva S; Moura-Ferreira P; Villaverde-Cabral M; Santos O; Carmo ID; Barros H; Lunet N
    Health Expect; 2017 Apr; 20(2):211-220. PubMed ID: 26914376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects.
    Braga R; Costa AR; Pina F; Moura-Ferreira P; Lunet N
    Eur J Cancer Prev; 2020 May; 29(3):248-251. PubMed ID: 31651568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health-related knowledge of primary prevention of cancer in Portugal.
    Costa AR; Silva S; Moura-Ferreira P; Villaverde-Cabral M; Santos O; do Carmo I; Barros H; Lunet N
    Eur J Cancer Prev; 2016 Jan; 25(1):50-3. PubMed ID: 25642793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
    Alves C; Alves L; Lunet N
    Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography use for breast cancer screening in Portugal: results from the 2005/2006 National Health Survey.
    Dourado F; Carreira H; Lunet N
    Eur J Public Health; 2013 Jun; 23(3):386-92. PubMed ID: 22874736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral cancer awareness and knowledge among residents in the Oporto city, Portugal.
    Monteiro LS; Warnakulasuriya S; Cadilhe S; Sousa D; Trancoso PF; Antunes L; Salazar F; Pacheco JJ
    J Investig Clin Dent; 2016 Aug; 7(3):294-303. PubMed ID: 25976280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knowledge about cancer screening programmes in Sardinia.
    Mereu A; Concu F; Dessì C; Girau M; Ionta MT; Lai L; Liori A; Masala M; McGilliard CD; Origa P; Piazza MF; Pisanu L; Soggiu B; Sotgiu A; Contu P; Sardu C
    J Prev Med Hyg; 2019 Dec; 60(4):E337-E342. PubMed ID: 31967090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Picturing Prevalence and Inequalities in Cancer Screening Attendance to Population-Based Programs in Portugal.
    Quintal C; Antunes M
    Acta Med Port; 2023 Sep; 36(9):577-587. PubMed ID: 37339163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer Screening Awareness and Practice in a Middle Income Country; A Systematic Review from Iran.
    Majidi A; Majidi S; Salimzadeh S; Khazaee- Pool M; Sadjadi A; Salimzadeh H; Delavari A
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3187-3194. PubMed ID: 29281865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that influence awareness of breast cancer screening among Arab women in Qatar: results from a cross sectional survey.
    Donnelly TT; Khater AH; Al-Bader SB; Al Kuwari MG; Malik M; Al-Meer N; Singh R; Fung T
    Asian Pac J Cancer Prev; 2014; 15(23):10157-64. PubMed ID: 25556441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.
    Andriole GL; Crawford ED; Grubb RL; Buys SS; Chia D; Church TR; Fouad MN; Isaacs C; Kvale PA; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hsing AW; Izmirlian G; Pinsky PF; Kramer BS; Miller AB; Gohagan JK; Prorok PC;
    J Natl Cancer Inst; 2012 Jan; 104(2):125-32. PubMed ID: 22228146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stigma and cancer screening attendance: a population based survey in England.
    Vrinten C; Gallagher A; Waller J; Marlow LAV
    BMC Cancer; 2019 Jun; 19(1):566. PubMed ID: 31185949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why colorectal screening fails to achieve the uptake rates of breast and cervical cancer screening: a comparative qualitative study.
    Kotzur M; McCowan C; Macdonald S; Wyke S; Gatting L; Campbell C; Weller D; Crighton E; Steele RJC; Robb KA
    BMJ Qual Saf; 2020 Jun; 29(6):482-490. PubMed ID: 31879320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Breast, Cervical and Prostate Cancers in Kazakhstan: Key Factors and Psychological Aspects.
    Shamsutdinova A; Turdaliyeva B; Tanabayeva S; Omarova A; Saliev T; Tanabayev B; Fakhradiyev I
    Asian Pac J Cancer Prev; 2023 Jul; 24(7):2515-2522. PubMed ID: 37505786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of a negative colorectal screening test result to symptom appraisal and help-seeking behaviour among patients subsequently diagnosed with an interval colorectal cancer.
    Barnett KN; Weller D; Smith S; Steele RJ; Vedsted P; Orbell S; Moss SM; Melia JW; Patnick J; Campbell C
    Health Expect; 2018 Aug; 21(4):764-773. PubMed ID: 29457677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in Cancer Screening in Vulnerable Populations? Results of the EDIFICE Surveys.
    Morère JF; Eisinger F; Touboul C; Lhomel C; Couraud S; Viguier J
    Curr Oncol Rep; 2018 Mar; 20(Suppl 1):17. PubMed ID: 29508084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attitudes and beliefs of non-participants in a population-based screening programme for colorectal cancer.
    Hall NJ; Rubin GP; Dobson C; Weller D; Wardle J; Ritchie M; Rees CJ
    Health Expect; 2015 Oct; 18(5):1645-57. PubMed ID: 24268129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in attitudes impeding colorectal cancer screening.
    Ritvo P; Myers RE; Paszat L; Serenity M; Perez DF; Rabeneck L
    BMC Public Health; 2013 May; 13():500. PubMed ID: 23706029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.